Tom Alapaattikoski

CEO, Brinter Inc

United States

Mr. Alapaattikoski (M.Sc., MBA) is an American-Finnish serial entrepreneur, investor, and biotech trailblazer from Santa Monica, CA, and North Carolina. Alapaattikoski is a co-founder and CEO of the Biotech/MedTech company BRINTER, which aims to revolutionize personalized cartilage reconstruction in rhinoplasty and orthopedics with its bioengineered universal cartilage. During his over 15 years of career building global growth companies, Alapaattikoski has been awarded several national & international awards and honors as an innovator, leader, & investor. Creativity, know-how in Tech, and an innovative mindset have been his steppingstone to a wide range of global connections and great friendships.

Sessions

26-Feb-2024

11:45 AM– 12:00 PM
Brinter Inc

It's the kind of meeting where biotech newsmakers can have productive dialogs with investors and other key players.

Luke Timmerman
The Timmerman Report
It's the caliber of attendees - biopharma companies on the verge of their next big step and investors looking for smart opportunities - that make BIO CEO & Investor Conference vital to the industry.

Anna Kazanchyan, MD
Founder & CEO, Saghmos Therapeutics
The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in the biopharma ecosystem.

Philip Ross, MD
Global Chairman, J.P. Morgan Healthcare Investment Banking
The BIO CEO & Investor Conference provides timely and relevant content on the issues driving the business of biotech, along with an invaluable platform for networking and partnering.

Chris Garabedian
Chairman and CEO, Xontogeny and Portfolio Manager, PXV Fund

2024 Speakers